Jackie M Clegg
CIK 1214792 · last filed 2019-02-13
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
BKD price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
WASHINGTON, DC 20002
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BKD | Director | 103,678 | $10.11 | $1.05M | -$162.1K | 39 | 2019-02-13 |
| CME | Director | 6,947 | $306.68 | $2.13M | -$315.8K | 12 | 2014-03-17 |
| JAVELIN PHARMACEUTICALS, INC (JAV) Delisted | Director | — | — | — | $0 | 5 | 2010-07-02 |
| BLOCKBUSTER INC (BBI.B) Delisted | Director | 163,494 | — | — | $0 | 7 | 2010-01-06 |
Recent Filings · Page 3 of 7
65 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-02-09 | BKD | Grant (A) | +2,892 | $0 | EDGAR |
| 2014-08-08 | BKD | Grant (A) | +2,992 | $0 | EDGAR |
| 2014-03-17 | CME | Gift (G) | −208 | $0 | EDGAR |
| 2014-01-03 | BKD | Grant (A) | +754 | $20.5K | EDGAR |
| 2013-12-17 | CME | Sell (S) | −2,000 | -$162.2K | EDGAR |
| 2013-10-03 | BKD | Grant (A) | +698 | $19.0K | EDGAR |
| 2013-07-03 | BKD | Grant (A) | +652 | $17.5K | EDGAR |
| 2013-06-27 | CME | Grant (A) | +982 | $0 | EDGAR |
| 2013-04-03 | BKD | Grant (A) | +772 | $21.2K | EDGAR |
| 2013-01-03 | BKD | Grant (A) | +720 | $18.2K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.